- Report
- May 2022
- 283 Pages
Global
From €3185EUR$3,500USD£2,731GBP
- Report
- May 2022
- 224 Pages
Global
From €3185EUR$3,500USD£2,731GBP
- Report
- May 2022
- 59 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2022
- 87 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- May 2022
- 124 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- August 2022
- 324 Pages
Global
From €3495EUR$3,840USD£2,996GBP
The Opioid Receptor market is a subset of the Addiction Disorders Drugs market. It is composed of drugs that interact with opioid receptors in the brain, which are responsible for controlling pain and pleasure. These drugs are used to treat pain, addiction, and other conditions. Commonly prescribed opioids include oxycodone, hydrocodone, and morphine. Opioid receptor drugs are also used to treat opioid addiction, as they can reduce cravings and withdrawal symptoms.
The Opioid Receptor market is highly regulated, as these drugs can be highly addictive and have serious side effects. As such, they are typically prescribed only when other treatments have failed. In addition, many countries have implemented policies to reduce the misuse of opioids.
Companies in the Opioid Receptor market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Johnson & Johnson. Show Less Read more